Mantle cell lymphoma (MCL) is an aggressive blood cancer. Relapsing after initial chemotherapy is a harsh reality for many patients. Traditional treatments often lose their effectiveness quickly. The disease returns rapidly. This leaves patients and
Ibrutinib Therapy for Relapsed Mantle Cell Lymphoma